Annual Operating Expenses
$41.76 M
+$5.23 M+14.32%
31 December 2023
Summary:
Larimar Therapeutics annual total operating expenses is currently $41.76 million, with the most recent change of +$5.23 million (+14.32%) on 31 December 2023. During the last 3 years, it has fallen by -$8.71 million (-17.25%). LRMR annual operating expenses is now -17.25% below its all-time high of $50.47 million, reached on 31 December 2021.LRMR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$18.26 M
-$6.33 M-25.75%
30 September 2024
Summary:
Larimar Therapeutics quarterly total operating expenses is currently $18.26 million, with the most recent change of -$6.33 million (-25.75%) on 30 September 2024. Over the past year, it has increased by +$4.10 million (+28.96%). LRMR quarterly operating expenses is now -25.75% below its all-time high of $24.60 million, reached on 30 June 2024.LRMR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LRMR Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +29.0% |
| 3 y3 years | -17.3% | +101.0% |
| 5 y5 years | +79.9% | +196.6% |
LRMR Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -17.3% | +14.3% | -25.8% | +139.2% |
| 5 y | 5 years | -17.3% | +79.9% | -25.8% | +196.6% |
| alltime | all time | -17.3% | +79.9% | -25.8% | +393.1% |
Larimar Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $18.26 M(-25.8%) |
| June 2024 | - | $24.60 M(+47.0%) |
| Mar 2024 | - | $16.73 M(+18.2%) |
| Dec 2023 | $41.76 M(+14.3%) | $14.16 M(+37.0%) |
| Sept 2023 | - | $10.34 M(+7.5%) |
| June 2023 | - | $9.62 M(+26.0%) |
| Mar 2023 | - | $7.64 M(-26.8%) |
| Dec 2022 | $36.53 M(-27.6%) | $10.44 M(+22.6%) |
| Sept 2022 | - | $8.51 M(-2.0%) |
| June 2022 | - | $8.69 M(-2.3%) |
| Mar 2022 | - | $8.89 M(-2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $50.47 M(+17.9%) | $9.09 M(-45.7%) |
| Sept 2021 | - | $16.73 M(+33.4%) |
| June 2021 | - | $12.54 M(+3.6%) |
| Mar 2021 | - | $12.11 M(-15.9%) |
| Dec 2020 | $42.80 M(+84.4%) | $14.40 M(+39.3%) |
| Sept 2020 | - | $10.34 M(-9.3%) |
| June 2020 | - | $11.40 M(+70.8%) |
| Mar 2020 | - | $6.67 M(+8.4%) |
| Dec 2019 | $23.21 M | $6.16 M(-28.6%) |
| Sept 2019 | - | $8.63 M(+132.9%) |
| June 2019 | - | $3.70 M |
FAQ
- What is Larimar Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Larimar Therapeutics?
- What is Larimar Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Larimar Therapeutics?
- What is Larimar Therapeutics quarterly operating expenses year-on-year change?
What is Larimar Therapeutics annual total operating expenses?
The current annual operating expenses of LRMR is $41.76 M
What is the all time high annual operating expenses for Larimar Therapeutics?
Larimar Therapeutics all-time high annual total operating expenses is $50.47 M
What is Larimar Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of LRMR is $18.26 M
What is the all time high quarterly operating expenses for Larimar Therapeutics?
Larimar Therapeutics all-time high quarterly total operating expenses is $24.60 M
What is Larimar Therapeutics quarterly operating expenses year-on-year change?
Over the past year, LRMR quarterly total operating expenses has changed by +$4.10 M (+28.96%)